Lisa Cabott Carson
CIK: 0002073513
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Phio Pharmaceuticals Corp.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 28, 2026PHIO
Phio Pharmaceuticals Corp.
Award(A)Direct108K shares- - Sep 11, 2026PHIO
Phio Pharmaceuticals Corp.
Tax Payment(F)Direct12.9K shares at avg. $1.03$13K - Feb 5, 2026PHIO
Phio Pharmaceuticals Corp.
Award(A)Direct47K shares- - Sep 11, 2025PHIO
Phio Pharmaceuticals Corp.
Award(A)Direct47K shares-
1-4 of 4 transactions
About Carson Lisa Cabott
Carson Lisa Cabott (SEC CIK 0002073513) files insider reports with the SEC as Chief Financial Officer of Phio Pharmaceuticals Corp. (PHIO).
Signal8 holds 5 ownership filings by Carson Lisa Cabott (1 Form 3, 4 Form 4), filed between Jun 18, 2025 and Sep 29, 2026. Those filings report 4 transactions, from Sep 11, 2025 to Sep 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Carson Lisa Cabott's filings is in KING OF PRUSSIA, PA.
Recent filings by Carson Lisa Cabott
Other insiders filing for Phio Pharmaceuticals Corp. (PHIO)
- Bitterman Robert J, Chairman, Pres. & CEO
- Plott Ronald Todd, Director
- BRADFORD PATRICIA A, Director
- Lockshin Curtis, Director
- Freeman Jonathan E, Director
- Deming David H, Director